Spine Wave green-lights on new spinal implant
The FDA has given Spine Wave the approval to sell its StaXx XDL, an implant that uses the company’s expandable-device technology to aid surgeons correcting spinal disorders.
Jürgen Harms, MD, medical director of the Center for Spinal Surgery in Karlsbad, Germany, helped develop the device. “While the clinical results are still very preliminary, my early experience has been very favorable,” he said in a company statement.
The StaXx XDL is the company’s first device intended to be implanted from the side of the spine. Lateral access offers a “minimally disruptive approach to the spine,” according to the Society of Lateral Access Surgery.
Privately-owned Spine Wave designs and markets medical devices for the treatment of spinal disorders. The Shelton, Conn.-based company said it focuses on “offering spine surgeons technologies to common surgical problems,” according to the release. Its website states that it closed its most recent financing round, with a $45 million deal from a group of investors led by Compass Global Fund, in 2007.
Jürgen Harms, MD, medical director of the Center for Spinal Surgery in Karlsbad, Germany, helped develop the device. “While the clinical results are still very preliminary, my early experience has been very favorable,” he said in a company statement.
The StaXx XDL is the company’s first device intended to be implanted from the side of the spine. Lateral access offers a “minimally disruptive approach to the spine,” according to the Society of Lateral Access Surgery.
Privately-owned Spine Wave designs and markets medical devices for the treatment of spinal disorders. The Shelton, Conn.-based company said it focuses on “offering spine surgeons technologies to common surgical problems,” according to the release. Its website states that it closed its most recent financing round, with a $45 million deal from a group of investors led by Compass Global Fund, in 2007.
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.